BHI
logo
  • Health Plans
    • Transparency Analytics
    • Plan Performance Analytics
    • Provider Analytics
    • Employer Analytics
    • Health Equity
    • Risk Adjustment
  • Real-World Evidence Generation
  • Resources
  • About
    • Company
    • Leadership
  • Careers
  • Contact Us
  • Subscribe

JUST RELEASED

Real-World Trends in GLP-1 Prescribing and Treatment Persistence for Weight Management

Millions of Americans struggle with obesity, which can lead to substantial health risks and disease. GLP-1 drugs offer a promising treatment for weight loss and improved health. But a key question is whether patients stick with the drug long enough to benefit. This study performed on behalf of the Blue Cross Blue Shield Association explores if people prescribed GLP-1s for weight loss are giving up on treatment too soon.

Millions of Americans struggle with obesity, which can lead to substantial health risks and disease. GLP-1 drugs offer a promising treatment for weight loss and improved health. But a key question is whether patients stick with the drug long enough to benefit. This study performed on behalf of the Blue Cross Blue Shield Association explores if people prescribed GLP-1s for weight loss are giving up on treatment too soon.

Read the Issue Brief

Sign up to receive updates from BHI

Subscribe
Hide filtersShow filters
× Close
  • Benchmarking
  • Boost Your Skills
  • COVID-19
  • Chronic disease management
  • Episode of Care Grouper
  • HITRUST
  • National Benchmarking
  • Physician performance
  • Population Advyzer
  • Predictive analytics
  • Prescription drugs
  • Price transparency
  • QE
  • REL data
  • Real-world data (RWD)
  • Risk Adjustment
  • Risk scoring
  • Transparency Analytics
  • artificial intelligence
  • behavioral health
  • cost transparency
  • employer analytics and reporting
  • health equity
  • hospital outpatient care
  • machine learning
  • medical device
  • real-world evidence (RWE)
  • site-neutral
  • telehealth
  • value-based care
  • whyzen analytics

Clear all Apply

News

Concert Genetics and BHI Partner to Speed the Growth of Genetic Testing

Case Studies

BHI Data is Helping Concert Genetics Connect a Genetic Health Information Network

News

BCBS of Louisiana Partners with BHI on Provider Reporting and Data Sharing

Reports

Cost of Care Snapshot: Report Summarizing Recent 3-Year Healthcare Trends

News

BHI and Datavant Partner in Linking Data and Analytics to Improve Healthcare

Reports

The Power of Pharmaceuticals: Rx Spending Outpaces Inpatient Hospital Spending 2018 & 2019

Case Studies

BHI Data Combined with ML Provides Insight into Chronic Disease Management

News

BHI and Decode Health Team Up to Validate Predictive Models for Chronic Disease

Case Studies

Data Supports Therapy Provider’s Claims of Lower Costs, Higher Quality

  • 1
  • …
  • 5
  • 6
  • 7

© 2024 Blue Health Intelligence. Blue Health Intelligence (BHI) is a trade name of Health Intelligence Company LLC, an independent licensee of the Blue Cross Blue Shield Association.

Privacy Preference Center

Privacy Preferences